The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Beyond PSA: The Next Generation of Prostate Cancer Biomarkers
Open accessAbstract
Prostate cancer biomarkers that improve upon the PSA test should address unmet clinical needs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Screening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,014
EAU Guidelines on Prostate Cancer
Heidenreich, A., Aus, G., Bolla, M., Joniau, S., Matveev, V. B., Schmid, H. P., & Zattoni, F. (2008) · European Urology · doi:10.1016/j.eururo.2007.09.002 · Cited by 3,136
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
Pound, C. R. (1999) · JAMA · doi:10.1001/jama.281.17.1591 · Cited by 3,071
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810696 · Cited by 2,906
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S., & Redwine, E. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710083171501 · Cited by 2,451
Thompson, I. M., Pauler, D. K., Goodman, P. J., Tangen, C. M., Lucia, M. S., Parnes, H. L., Minasian, L. M., Ford, L. G., Lippman, S. M., Crawford, E. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031918 · Cited by 2,446
Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J. J., Petros, J. A., & Andriole, G. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241702 · Cited by 2,361
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., Lin, X., Greenfield, T. K., Litwin, M. S., Saigal, C. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074311 · Cited by 2,253
Self-citationMetabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,234
Self-citationde Bono, J. S., Scher, H. I., Montgomery, R. B., Parker, C., Miller, M. C., Tissing, H., Doyle, G. V., Terstappen, L. W. W. M., Pienta, K. J., & Raghavan, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0872 · Cited by 2,182
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji237 · Cited by 2,162
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Rifai, N., Gillette, M. A., & Carr, S. A. (2006) · Nature Biotechnology · doi:10.1038/nbt1235 · Cited by 1,867
Welch, H. G., & Black, W. C. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq099 · Cited by 1,599
The genomic complexity of primary human prostate cancer
Berger, M. F., Lawrence, M. S., Demichelis, F., Drier, Y., Cibulskis, K., Sivachenko, A. Y., Sboner, A., Esgueva, R., Pflueger, D., Sougnez, C., et al. (2011) · Nature · doi:10.1038/nature09744 · Cited by 1,234
Self-citationCarver, B. S., Chapinski, C., Wongvipat, J., Hieronymus, H., Chen, Y., Chandarlapaty, S., Arora, V. K., Le, C., Koutcher, J., Scher, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.008 · Cited by 1,198
Catalona, W. J., Partin, A. W., Slawin, K. M., Brawer, M. K., Flanigan, R. C., Patel, A., Richie, J. P., deKernion, J. B., Walsh, P. C., Scardino, P. T., et al. (1998) · JAMA · doi:10.1001/jama.279.19.1542 · Cited by 1,162
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
Bussemakers, M. J. G., van Bokhoven, A., Verhaegh, G. W. C. T., Smit, F. P., Karthaus, H. F. M., Schalken, J. A., Debruyne, F. M. J., Ru, N., & Isaacs, W. B. (1999) · PubMed · Cited by 1,051
Dissemination and publication of research findings: an updated review of related biases
Song, F., Parekh, Hooper, L., Loke, Y., Ryder, J., Sutton, A., Hing, C., Kwok, C., Pang, C., & Harvey, I. (2010) · Health Technology Assessment · doi:10.3310/hta14080 · Cited by 1,039
Prensner, J. R., Iyer, M. K., Balbin, O. A., Dhanasekaran, S. M., Cao, Q., Brenner, J. C., Laxman, B., Asangani, I. A., Grasso, C. S., Kominsky, H. D., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1914 · Cited by 1,029
Self-citationSawyers, C. L. (2008) · Nature · doi:10.1038/nature06913 · Cited by 983
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
Wolf, A. M. D., Wender, R. C., Etzioni, R. B., Thompson, I. M., D'Amico, A. V., Volk, R. J., Brooks, D. D., Dash, C., Guessous, I., Andrews, K., et al. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20066 · Cited by 965
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
Lilja, H., Ulmert, D., & Vickers, A. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2351 · Cited by 921
Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin
Lilja, H., Christensson, A., Dahlén, U., Matikainen, M. T., Nilsson, O., Pettersson, K., & Lövgren, T. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.9.1618 · Cited by 910
Draisma, G., Etzioni, R., Tsodikov, A., Mariotto, A., Wever, E., Gulati, R., Feuer, E., & de Koning, H. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp001 · Cited by 796
Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
Nilsson, J., Skog, J., Nordstrand, A., Baranov, V, Mincheva-Nilsson, L., Breakefield, X. O., & Widmark, A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605058 · Cited by 776
Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy
D'Amico, A. V., Chen, M.-H., Roehl, K. A., & Catalona, W. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032975 · Cited by 740
Biology of Prostate-Specific Antigen
Balk, S. P., Ko, Y.-J., & Bubley, G. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.083 · Cited by 718
Pepe, M. S., Feng, Z., Janes, H., Bossuyt, P. M., & Potter, J. D. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn326 · Cited by 717
Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer
Danila, D. C., Heller, G., Gignac, G. A., Gonzalez-Espinoza, R., Anand, A., Tanaka, E., Lilja, H., Schwartz, L., Larson, S., Fleisher, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1506 · Cited by 665
Germline Mutations in HOXB13 and Prostate-Cancer Risk
Ewing, C. M., Ray, A. M., Lange, E. M., Zuhlke, K. A., Robbins, C. M., Tembe, W. D., Wiley, K. E., Isaacs, S. D., Johng, D., Wang, Y., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110000 · Cited by 658
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
Demichelis, F., Fall, K., Perner, S., Andrén, O., Schmidt, F., Setlur, S. R., Hoshida, Y., Mosquera, J.-M., Pawitan, Y., Lee, C., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210237 · Cited by 645
Self-citationα-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer
Rubin, M. A. (2002) · JAMA · doi:10.1001/jama.287.13.1662 · Cited by 644
Self-citationCumulative Association of Five Genetic Variants with Prostate Cancer
Zheng, S. L., Sun, J., Wiklund, F., Smith, S., Stattin, P., Li, G., Adami, H.-O., Hsu, F.-C., Zhu, Y., Bälter, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa075819 · Cited by 631
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
Roychowdhury, S., Iyer, M. K., Robinson, D. R., Lonigro, R. J., Wu, Y.-M., Cao, X., Kalyana-Sundaram, S., Sam, L., Balbin, O. A., Quist, M. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003161 · Cited by 628
Self-citationDD3(PCA3), a very sensitive and specific marker to detect prostate tumors.
de Kok, J. B., Verhaegh, G. W. C. T., Roelofs, R., Hessels, D., Kiemeney, L. A. L. M., Aalders, T. W., Swinkels, D. W., & Schalken, J. A. (2002) · PubMed · Cited by 607
Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou, R., Croswell, J. M., Dana, T., Bougatsos, C., Blazina, I., Fu, R., Gleitsmann, K., Koenig, H. C., Lam, C., Maltz, A., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-11-201112060-00375 · Cited by 573
REporting recommendations for tumor MARKer prognostic studies (REMARK)
for the Statistics Subcommittee of the NCI—EORTC Working Group on Cancer Diagnostics (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0252 · Cited by 561
Carter, H. B., Ferrucci, L., Kettermann, A., Landis, P., Wright, E. J., Epstein, J. I., Trock, B. J., & Metter, E. J. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj410 · Cited by 556
Attard, G., Swennenhuis, J. F., Olmos, D., Reid, A. H. M., Vickers, E., A'Hern, R., Levink, R., Coumans, F., Moreira, J., Riisnaes, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3667 · Cited by 533
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
Leary, R. J., Kinde, I., Diehl, F., Schmidt, K., Clouser, C., Duncan, C., Antipova, A., Lee, C., McKernan, K., De La Vega, F. M., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000702 · Cited by 517
Rethinking Screening for Breast Cancer and Prostate Cancer
Esserman, L. (2009) · JAMA · doi:10.1001/jama.2009.1498 · Cited by 516
Gillet, J.-P., Calcagno, A. M., Varma, S., Marino, M., Green, L. J., Vora, M. I., Patel, C., Orina, J. N., Eliseeva, T. A., Singal, V., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111840108 · Cited by 477 · cited 1×
“Scie cause many preclinical models poorly reflect human disease, including cell lines (58).”
BackgroundClinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
Haese, A., de la Taille, A., van Poppel, H., Marberger, M., Stenzl, A., Mulders, P. F. A., Huland, H., Abbou, C.-C., Remzi, M., Tinzl, M., et al. (2008) · European Urology · doi:10.1016/j.eururo.2008.06.071 · Cited by 455
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
Attard, G., Clark, J., Ambroisine, L., Fisher, G., Kovacs, G., Flohr, P., Berney, D., Foster, C. S., Fletcher, A., Gerald, W. L., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1210640 · Cited by 438
Brenner, J. C., Ateeq, B., Li, Y., Yocum, A. K., Cao, Q., Asangani, I. A., Patel, S., Wang, X., Liang, H., Yu, J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.010 · Cited by 415
Self-citationA First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer
Laxman, B., Morris, D. S., Yu, J., Siddiqui, J., Cao, J., Mehra, R., Lonigro, R. J., Tsodikov, A., Wei, J. T., Tomlins, S. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3224 · Cited by 409
Self-citationAn Assessment of Radical Prostatectomy: Time Trends, Geographic Variation, and Outcomes
Lu-Yao, G. L. (1993) · JAMA · doi:10.1001/jama.1993.03500200047031 · Cited by 402
Cancer Biomarkers: Can We Turn Recent Failures into Success?
Diamandis, E. P. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq306 · Cited by 376
Randomized Clinical Trials With Biomarkers: Design Issues
Freidlin, B., McShane, L. M., & Korn, E. L. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp477 · Cited by 369
Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
Tomlins, S. A., Aubin, S. M. J., Siddiqui, J., Lonigro, R. J., Sefton-Miller, L., Miick, S., Williamsen, S., Hodge, P., Meinke, J., Blase, A., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001970 · Cited by 350
Self-citationHessels, D., Smit, F. P., Verhaegh, G. W., Witjes, J. A., Cornel, E. B., & Schalken, J. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0700 · Cited by 334
Predictive biomarkers: a paradigm shift towards personalized cancer medicine
La Thangue, N. B., & Kerr, D. J. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.121 · Cited by 332
Yoshimoto, M., Joshua, A. M., Cunha, I. W., Coudry, R. A., Fonseca, F. P., Ludkovski, O., Zielenska, M., Soares, F. A., & Squire, J. A. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.96 · Cited by 279
Exosomes as Biomarker Treasure Chests for Prostate Cancer
Duijvesz, D., Luider, T., Bangma, C. H., & Jenster, G. (2011) · European Urology · doi:10.1016/j.eururo.2010.12.031 · Cited by 278
Applying What We Know to Accelerate Cancer Prevention
Colditz, G. A., Wolin, K. Y., & Gehlert, S. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003218 · Cited by 268
Advancements in MR Imaging of the Prostate: From Diagnosis to Interventions
Bonekamp, D., Jacobs, M. A., El-Khouli, R., Stoianovici, D., & Macura, K. J. (2011) · RadioGraphics · doi:10.1148/rg.313105139 · Cited by 254
Comparative Effectiveness and Health Care Spending — Implications for Reform
Weinstein, M. C., & Skinner, J. A. (2010) · New England Journal of Medicine · doi:10.1056/nejmsb0911104 · Cited by 247
TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
Gopalan, A., Leversha, M. A., Satagopan, J. M., Zhou, Q., Al-Ahmadie, H. A., Fine, S. W., Eastham, J. A., Scardino, P. T., Scher, H. I., Tickoo, S. K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2467 · Cited by 246
Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer
Tavoosidana, G., Ronquist, G., Darmanis, S., Yan, J., Carlsson, L., Wu, D., Conze, T., Ek, P., Semjonow, A., Eltze, E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019330108 · Cited by 244
Carter, H. B., Morrell, C. H., Pearson, J. D., et al. (1992) · PubMed · Cited by 240
The use of PCA3 in the diagnosis of prostate cancer
Hessels, D., & Schalken, J. A. (2009) · Nature Reviews Urology · doi:10.1038/nrurol.2009.40 · Cited by 239
Selective Reporting Biases in Cancer Prognostic Factor Studies
Kyzas, P. A., Loizou, K. T., & Ioannidis, J. P. A. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji184 · Cited by 231
Han, B., Mehra, R., Lonigro, R. J., Wang, L., Suleman, K., Menon, A., Palanisamy, N., Tomlins, S. A., Chinnaiyan, A. M., & Shah, R. B. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.69 · Cited by 227
Self-citationSircar, K., Yoshimoto, M., Monzon, F. A., Koumakpayi, I. H., Katz, R. L., Khanna, A., Alvarez, K., Chen, G., Darnel, A. D., Aprikian, A. G., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2559 · Cited by 208
Jiang, Z., Fanger, G. R., Woda, B. A., Banner, B. F., Algate, P., Dresser, K., Xu, J., & Chu, P. G. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00268-5 · Cited by 198
Main, C., Moxham, T., Wyatt, J. C., Kay, J., Anderson, R., & Stein, K. (2010) · Health Technology Assessment · doi:10.3310/hta14480 · Cited by 166
Ransohoff, D. F. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.04.020 · Cited by 163
Sardana, G., Jung, K., Stephan, C., & Diamandis, E. P. (2008) · Journal of Proteome Research · doi:10.1021/pr8003216 · Cited by 161
Emerging Biomarkers for the Diagnosis and Prognosis of Prostate Cancer
Sardana, G., Dowell, B. L., & Diamandis, E. P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.110668 · Cited by 156
Walsh, P. C. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.01.012 · Cited by 154
Diagnosis of adenocarcinoma in prostate needle biopsy tissue
Humphrey, P. A. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.036442 · Cited by 150
Tumour banks: well-guarded treasures in the interest of patients
Oosterhuis, J. W., Coebergh, J. W. W., & van Veen, E.-B. (2003) · Nature reviews. Cancer · doi:10.1038/nrc973 · Cited by 131
Asymptomatic Incidence and Duration of Prostate Cancer
Etzioni, R., Cha, R., Feuer, E. J., & Davidov, O. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009698 · Cited by 127
Rubin, M. A., Bismar, T. A., Andrén, O., Mucci, L. A., Kim, R., Shen, R., Ghosh, D., Wei, J. T., Chinnaiyan, A. M., Adami, H., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0801 · Cited by 125
Self-citationBiomarker studies: a call for a comprehensive biomarker study registry
André, F., McShane, L. M., Michiels, S., Ransohoff, D. F., Altman, D. G., Reis-Filho, J. S., Hayes, D. F., & Pusztai, L. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.4 · Cited by 118
Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling
Zhao, L., Lee, B. Y., Brown, D. A., Molloy, M. P., Marx, G. M., Pavlakis, N., Boyer, M. J., Stockler, M. R., Kaplan, W. H., Breit, S. N., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4901 · Cited by 105
Fine, S. W., Gopalan, A., Leversha, M. A., Al‐Ahmadie, H. A., Tickoo, S. K., Zhou, Q. C., Satagopan, J. M., Scardino, P. T., Gerald, W. L., & Reuter, V. E. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.120 · Cited by 103
Breast cancer assessment tools and optimizing adjuvant therapy
Oakman, C. A., Santarpia, L., & Leo, A. D. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.170 · Cited by 97
False-negative Prostate Needle Biopsies: Frequency, Histopathologic Features, and Follow-up
Wolters, T., van der Kwast, T., Vissers, C. J., Bangma, C. H., Roobol, M. J., Schröder, F. H., & van Leenders, G. J. L. H. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181c3ece9 · Cited by 88
Oncogenic gene fusions in epithelial carcinomas
Prensner, J. R., & Chinnaiyan, A. M. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.11.008 · Cited by 82
Self-citationFowler, F. J., Barry, M. J., Walker-Corkery, B., Caubet, J.-F., Bates, D. W., Lee, J. M., Hauser, A., & McNaughton‐Collins, M. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00464.x · Cited by 79
Meta‐analysis of genome‐wide and replication association studies on prostate cancer
Liu, H., Wang, B., & Han, C. (2010) · The Prostate · doi:10.1002/pros.21235 · Cited by 67
Rational approach to implementation of prostate cancer antigen 3 into clinical care
Wang, R., Chinnaiyan, A. M., Dunn, R. L., Wojno, K. J., & Wei, J. T. (2009) · Cancer · doi:10.1002/cncr.24447 · Cited by 60
Self-citationMRI of the prostate: Clinical relevance and emerging applications
Mazaheri, Y., Shukla‐Dave, A., Muellner, A., & Hricak, H. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22420 · Cited by 47
Predicting Prostate Cancer Biochemical Recurrence Using a Panel of Serum Proteomic Biomarkers
Rosenzweig, C. N., Zhang, Z., Sun, X., Sokoll, L. J., Osborne, K., Partin, A. W., & Chan, D. W. (2009) · The Journal of Urology · doi:10.1016/j.juro.2008.10.142 · Cited by 35
Asymptomatic Incidence and Duration of Prostate Cancer
Etzioni, R., Cha, R., Feuer, E. J., & Davidov, O. (1999) · The Journal of Urology · doi:10.1097/00005392-199907000-00083 · Cited by 32
HISTORY, CHARACTER, AND DIAGNOSTIC PROSPECTS*
Anderson, N. L., & Anderson, N. G. (2002) · Cited by 26
Cited by
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Prensner, J. R., Iyer, M. K., Sahu, A., Asangani, I. A., Cao, Q., Patel, L., Vergara, I. A., Davicioni, E., Erho, N., Ghadessi, M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2771 · Cited by 669
Self-citationCopy number alteration burden predicts prostate cancer relapse
Hieronymus, H., Schultz, N., Gopalan, A., Carver, B. S., Chang, M. T., Xiao, Y., Heguy, A., Huberman, K., Bernstein, M., Assel, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411446111 · Cited by 364
Lalonde, E., Ishkanian, A. S., Sykes, J., Fraser, M., Ross-Adams, H., Erho, N., Dunning, M. J., Halim, S., Lamb, A. D., Moon, N. C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71021-6 · Cited by 342
PSA and beyond: alternative prostate cancer biomarkers
Saini, S. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0268-6 · Cited by 295
Metadata
- Authors
- Prensner, J. R., Rubin, M. A., Wei, J. T., & Chinnaiyan, A. M.
- Venue
- Science Translational Medicine
- Published
- 2012-03-28
- Volume
- 4
- Issue
- 127
- Pages
- 127rv3-127rv3
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2019549684
- Cited by
- 472
- References
- 93
- FWCI
- 31.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.